Blueprint
MONOPAR
THERAPEUTICS INC.
CONFIRMING
STATEMENT
REGARDING
AUTHORITY TO EXECUTE SECTION 16(a) REPORTS
This
Statement confirms that the undersigned, Raymond William Anderson
c/o Monopar Therapeutics Inc., 1000 Skokie Blvd., Suite 350,
Wilmette, IL 60091 (the “Insider”), has authorized and
designated Kim R. Tsuchimoto and Chandler Robinson of Monopar
Therapeutics Inc. (the “Company”), Ashley Graffeo and
Robert Rupp, Esq. of Baker & Hostetler LLP, the Company’s
United States legal counsel, and each of them (each of the
foregoing is referred to as an “Authorized Signer”) to
execute and file on the Insider’s behalf a Form ID and any
and all Forms 3, 4 and 5 (including any amendments thereto) that
the Insider may be required to file with the United States
Securities and Exchange Commission under Section 16(a) of the
Securities Exchange Act of 1934, as a result of the Insider’s
ownership of, or transactions in, securities of the Company. The
authority of the Authorized Signers under this Confirming Statement
shall continue until the Insider is no longer required to file
Forms 3, 4 and 5 with regard to the Insider’s ownership of,
or transactions in, securities of the Company, unless earlier
revoked in writing. The Insider acknowledges that none of the
Authorized Signers is assuming any of the Insider’s
responsibilities to comply with Section 16 of the Securities
Exchange Act of 1934.
/s/
Raymond William Anderson
---------------------------------------
Raymond
William Anderson